Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles

Journal of Controlled Release

Volumn 49, Issue 1, 1997, Pages 81-87

  Kreuter, J ^a   Petrov, V E ^b   Kharkevich, D A ^b   Alyautdin, R N ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Blood brain barrier; Brain delivery; Dalargin; Enkephalin; Nanoparticles; Polysorbate; Surfactants

Indexed keywords

CREMOPHOR; ENBUCRILATE; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 ARGININE]; NANOPARTICLE; POLIDOCANOL; POLOXAMER; POLYSORBATE 20; POLYSORBATE 40; POLYSORBATE 60; POLYSORBATE 80; SURFACTANT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG COATING; DRUG RELEASE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030853702     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00061-8     Document Type: Article

References (16)

1. Alyautdin R., Gothier D., Petrov V., Kharkevich D., Kreuter J. Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 41:1995;44-48.
2. Kreuter J., Alyautdin R.N., Kharkevich D.A., Ivanov A.A. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res. 674:1995;171-174.
3. Schröder V., Sabel B.A. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res. 710:1996;121-124.
4. R.N. Alyautdin, A. Reichel, A. Sardini, R. Löbenberg, J. Kreuter, D.J. Begley, Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro. Brain Res. (submitted for publication).
5. Alyautdin R.N., Petrov V.E., Langer K., Berthold A., Kharkevich D.A., Kreuter J. Delivery of Loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Pharm. Res. 14:1997;325-328.
6. R.N. Alyautdin, E.B. Tezikov, P. Ramge, D.A. Kharkevich, D.J. Begley, J. Kreuter, Significant entry of tubocurarine into the brain of the rat is enabled by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: An in situ brain perfusion study, J. Microencapsul. (in press).
7. Tröster S.D., Müller U., Kreuter J. Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactants. Int. J. Pharm. 61:1990;85-100.
8. Illum L., Davis S.S. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (poloxamer 338). FEBS Lett. 167:1984;79-82.
9. Illum L., Davis S.S., Müller R.H., Mak E., West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer-poloxamine 908. Life Sci. 40:1987;367-374.
10. Borchard G., Audus K.L., Shi F., Kreuter J. Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayers. Int. J. Pharm. 110:1994;29-35.
11. D'Amour F.D., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
12. Nance P.W., Sawinok J. Substance P-induced long-term blockade of spinal adrenergic analgesia: reversal by morphine and naloxone. J. Pharmacol. Exp. Ther. 240(3):1987;972-977.
13. Araujo L., Kreuter J. Modification of the body distribution of polymethylmethacrylate nanoparticles by coating with different concentrations of non-ionic surfactants. Proc. Int. Symp. Control. Rel. Bioact. Mater. 22:1995;554-555.
14. Kreuter J. Evaluation of nanoparticles as drug-delivery systems. III: Materials, stability toxicity, possibilities of targeting, and use. Pharm. Acta Helv. 58:1983;242-250.
15. Blunk T., Hochstrasser D.F., Müller B.W., Müller R.H. Differential adsorption: Effect of plasma protein adsorption patterns on organ distribution of colloidal drug carriers. Proc. Int. Symp. Control. Rel. Bioact. Mater. 20:1993;256-257.
16. Blunk T., Hochstrasser D.F., Sanchez J.-C., Müller B.W., Müller R.H. Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface-modified latex particles evaluated by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 14:1993;1382-1387.